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Growth factors are the key elements in wound healing signaling for cell migration, 
differentiation and proliferation. Platelet-rich plasma (PRP), one of the most studied 
sources of growth factors, has demonstrated to promote wound healing in vitro and in 
vivo. Adipose tissue is an alternative source of growth factors. Through a simple 
lipoaspirate method, adipose derived growth factor-rich preparation (Adipose Tissue 
Extract; ATE) can be obtained. The authors set out to compare the effects of these two 
growth factor sources in cell proliferation and migration (scratch) assays of keratinocyte, 
fibroblast, endothelial and adipose derived stem cells. Growth factors involved in wound 
healing were measured: keratinocyte growth factor, epidermal growth factor, insulin-like 
growth factor, interleukin 6, platelet-derived growth factor beta, tumor necrosis factor 
alfa, transforming growth factor beta and vascular endothelial growth factor. PRP 
showed higher growth factor concentrations, except for keratinocyte growth factor, that 
was present in adipose tissue in greater quantities. This was reflected in vitro, where 
ATE significantly induced proliferation of keratinocytes at day 6 (p<0.001), compared to 
plasma and control.  Similarly, ATE -treated fibroblast and adipose stem cell cultures 
showed accelerated migration in scratch assays. Moreover, both sources showed 
accelerated keratinocyte migration. Adipose tissue preparation has an inductive effect 
in wound healing by proliferation and migration of cells involved in wound closure. 
Adipose tissue preparation appears to offer the distinct advantage of containing the 
adequate quantities of growth factors that induce cell activation, proliferation and 
migration, particularly in the early phase of wound healing. 
Key words: platelet-rich plasma, adipose tissue extract, growth factors, cell 
proliferation, biomedical engineering. 
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1. Introduction  
Chronic wounds affect more than 6 million people in the US with costs 
estimated at 9.7 billion dollars a year (Bickers et al 2006). To date, a myriad of tissue 
regeneration products are available in the market, but are either too costly or 
ineffective in promoting accelerated wound healing (Tamama and Kerpedjieva 2012).  
Wound healing is a complex signaling process where keratinocyte, endothelial cell and 
fibroblast migration and proliferation are the key players. Whilst keratinocytes 
promote ultimate wound coverage, fibroblasts play an active role in inducing 
keratinocyte proliferation and migration providing a stable vascularized bed of 
granulating tissue.  In the latter, endothelial cells form a rich network of blood vessels 
that bestows an oxygen and nutrient-rich foundation through which cells migrate for 
wound closure and scar formation. (Broughton et al., 2006, Guo and DiPietro 2010).  
Mesenchymal and adipose derived stem cells are known to participate in all phases of 
wound healing by proliferating and differentiating into different cell lineages thus 
promoting and accelerating repair (Lee et al., 2016), (Hassan et al., 2014).  
The role of growth factors in the complex and overlapping phases of wound healing 
has been studied consistently over time (Lee et al., 2016), (Hassan et al., 2014), 
(Demidova-Rice et al., 2012). In response to injury, platelets degranulate releasing 
epidermal growth factor (EGF), platelet derived growth factor beta (PDGF-B), 
keratinocyte growth factor (KGF), basic fibroblast growth factor (bFGF), and a series 
of interleukins (such as IL-8), insulin-like growth factor 1 (IGF-1), transforming 
growth factor beta (TGF-β) and tumor necrosis factor alpha (TNFα), among others 
(Cohen 2008, Nolte et al., 2008). These chemoattract neutrophils, which 
decontaminate the wound bed and stimulate macrophages to remove detritus through 
phagocytosis (Werner and Grose 2003). Subsequently, the proliferative phase (3-5 
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days of injury) is composed of fibroplasia, granulation and epithelization (Demidova-
Rice et al., 2012). Fibroblast proliferation, migration and extracellular matrix 
formation is stimulated by TGF-β, bFGF and PDGF-B and the following wound 
epithelialization is induced by EGF, KGF, TGF-α and bFGF. (Wright et al., 2009), 
(Demidova-Rice et al., 2012).  Simultaneously, VEGF and bFGF promote 
angiogenesis. The last phase of wound healing, where mature scar tissue is formed 
(remodelation), is mediated by bFGF, TGF-β and PDGF-B (Nolte et al., 2008), 
(Wright et al., 2009).   
It has been suggested that there is a deficit of growth factors in chronic wounds and 
that the use of exogenous growth factors brings benefits to the healing process 
(Demidova-Rice et al., 2012). In order to mimic what occurs physiologically in 
wounds, researchers have isolated growth factors from whole blood (platelet-rich 
plasma; PRP) or therapeutically used single recombinant factors, such as PDGF-B 
(Fonder et al., 2008), (Balfour and Noble 1999). PRP is an abundant source of platelet-
derived growth factors that has demonstrated positive wound healing effects in vivo and 
in vitro (Demidova-Rice et al., 2012). Nonetheless, several randomized control trials 
have failed to find benefit in its use (Montalvan et al. 2016), (Foster et al. 2009). One of 
the reasons for this is that there are many variations in the methodology of PRP 
preparation, such as the amount of blood extracted, centrifugation speed, number of 
spins, activation agents, and final layer of plasma included, resulting in a lack in 
consistency in growth factor yield (Leitner et al. 2006), (Rutkowski et al. 2008) and 
variations in clinical results (Weibrich et al. 2002), (Salamanna et al. 2015). Thus, 
there is an imperative need for a new reliable source of growth factors to promote wound 
healing. 
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 Subcutaneous adipose tissue, easily available through lipoaspiration, is a rich 
source of growth factors and cytokines (Zhao et al., 2013). Research has demonstrated 
the presence of cytokines such as leptin, adiponectin, angiotensin, adipsin, resistin, 
prostaglandins, glucocorticoids, interleukins (IL-1B, -6,-8,-10), hepatocyte growth factor 
(HGF), VEGF, bFGF, IGF-1, TGFα and β and angiopoietins 1 and 2 (Ang-1 and Ang-2) 
in adipose tissue, particularly in its stromal vascular fraction and mesenchymal stem 
cells (Bunnell et al., 2008), (Salgado et al., 2010). Although current attention has 
deviated towards stem cell research, the whole adipose tissue secretome contains a 
plethora of cytokines (Li et al., 2014), (Li et al., 2015), (Lee et al., 2014).  
We have previously extracted proteins and growth factors from whole adipose tissue and 
demonstrated that adipose tissue derived preparation  (Adipose Tissue Extract, ATE) 
contains cytokines with adipogenic and angiogenic properties (Sarkanen et al., 2012a), 
(Sarkanen et al., 2012b). Furthermore, we have developed a simple standardized 
method to prepare autologous ATE in an operating theater setting for clinical use, with 
minimal sample variability regardless of patient age, gender or body mass index (Lopez 
et al., 2016). The aim of our present study was to investigate the wound healing 
properties of our novel agent, ATE and clinically used wound treatment PRP in in vitro 
cell migration and proliferation assays and to characterize their growth factor content 
while comparing their wound healing properties.  
 
2. Material and Methods 
2.1 Ethical considerations 
The study was approved by the Ethics Committee of the Pirkanmaa District (R15034). 
13 lipoaspirate (ATE) and 11 blood (PRP) samples were obtained with patient informed 
consent.  
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2.2 Platelet rich plasma collection 
The PRP was prepared with GLO Pro kit (Glofinn Oy, Salo, Finland) according to the 
manufacturer’s instructions. Briefly, 9ml of whole blood was combined with 1ml of 
sodium citrate in a syringe and centrifuged at 1200 x g for 5 min. The excess red blood 
cells in the bottom of the syringe were removed and the syringe centrifuged at 1200 x g 
for 10 min. PRP was then obtained and activated with 10% calcium gluconate and 
autologous thrombin according to manufacturer’s instructions. Platelet activation was 
observed as a formation of a gel. The supernatant of the activated PRP was stored at -
20°C prior to analysis. 
2.3 Adipose tissue derived preparation (adipose tissue extract, ATE)  
Preparation of ATE following previously published procedures (Lopez et al., 2016). 
Briefly, subcutaneous infiltration of tumescent solution composed of 1000 ml of pre-
warmed Ringer lactate + 1 ml of adrenaline was performed in the lower abdomen with 
the water assisted liposuction technique (Bodyjet, HumanMed, Germany). 100-200 ml 
of adipose tissue and lipoaspirate liquid were collected in a sterile canister 
(LipoCollector, Human Med, Germany) and processed under sterile conditions. The fat 
was incubated at room temperature for 30 min. The decanted liquid was sterile filtered 
(Acrodisc®, Pall Corporation, NY, USA) prior to use. The adipose tissue preparation 
ATE , samples were stored at -20°C until analysis.  
2.4 Measurement of protein concentration 
Using Pierce™ BCA Protein Assay Kit (Thermo Scientific, MA, USA) according to 
manufacturer’s instructions, total protein content was quantified using BSA as a 
standard. Measurements were performed at 562 nm with Varioskan™ Flash Multimode 
Reader (Thermo Scientific).  
2.5 Measurement of growth factor concentration 
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Colorimetric sandwich ELISA Custom human cytokine and Angiogenesis strips (both 
from Signosis®, CA, USA) were used for EGF, IGF-I, IL-6, PDGF-B, TNF-α, TGF-β, 
FGF-β and VEGF, and KGF Kit (Boster Biological Technology Co, Ltd, CA, USA) for 
KGF to measure the amount of individual growth factors. Assays performed according 
to manufacturer instructions and measured at 450 nm with Varioskan Flash multimode 
reader (Thermo Scientific).   
2.6 Cell culture 
Human keratinocytes (HaCaT; ATCC, Manassas, VA, USA) were cultured in DMEM 
(Lonza, Basel, Switzerland) supplemented with 1% L-glutamine (Gibco, NY, USA), 1% 
antibiotics and 10% FBS (Gibco). Human foreskin fibroblasts (BJ; ATCC CRL-2522) 
were cultured in MEM, 10% FBS and 1% L-glutamine. Human adipose stem cells 
(hASC) were isolated as stromal cell fraction from adipose tissue obtained from surgical 
samples of healthy volunteers with informed consent (ethics approval no. R03058) from 
the Tampere University Hospital as described previously (Sarkanen JR, Vuorenpää H, 
Huttala O, Mannerström B, Kuokkanen H, Miettinen S, Heinonen T, Ylikomi T. 
2012)  hASC medium included DMEM/F12, 10% Human Serum AB ( Biowest, 
Nuaillé, France) and 1% L-glutamine. Human umbilical vein endothelial cells (HUVEC) 
were isolated from umbilical cords obtained from scheduled caesarean sections from 
healthy volunteers with informed consent (ethics approval no. R08028) as described 
previously (Sarkanen et al.,  2012) and cultured in EGM-2 (Endothelial Medium Bullet 
Kit, Lonza). 
2.7 Cell proliferation Assay 
Cell proliferation reagent Presto blue was employed to detect the growth of adipose stem 
cells, fibroblasts, endothelial cells and keratinocytes. Before the study, the cell number 
for each cell type was optimized so that the control would reach confluency within 6 
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days. In brief, cells were plated as monocultures in 96-well plates at following densities: 
keratinocytes 7500 cells/cm2, fibroblasts 5000 cells/ cm2, adipose stem cells 5000 
cells/cm2 and endothelial cells 7500 cells/cm2. A maximum of 50% of the culture medium 
volume (corresponding to 450 µg/ml) of ATE (n=10) and 10% (n=7) PRP were added to 
cells in their respective culture media. Presto blue (Life Technologies, Invitrogen 
Corporation, USA) cell viability reagent was added to each well and incubated until a 
visible change in color was observed. Fluorometric analysis was performed at excitation 
570 nm and emission 600 nm with Varioskan Flash Multimode Reader (Thermo 
Scientific) at 0, 1, 3 and 6 days of culture. The results derived from eight (ATE) or seven 
(PRP) independent experiments were performed in duplicate or triplicate. 
2.8 Scratch wound assay 
For scratch wound assay, prior to the study, a cell number optimization study was 
performed for each cell type (data not shown). The cell number was optimized to reach 
confluent cell monolayer at 24 hours. For the scratch wound assay, 48-well plates were 
then plated with the following cell counts: keratinocytes 300000 cells/cm2, fibroblasts 
100000 cells/cm2, adipose stem cells 100000 cells/cm2 and endothelial cells 150000 
cells/cm2. The day after plating, the confluent monolayer in each well was scraped with 
a pipette tip to create a vertical scratch in each plate. In order to precisely find the same 
position for measurement, the center of each well was labeled with a horizontal line. 
In order to remove the cell debris after the scratch, the cells were washed once with 
growth medium after which ATE or PRP samples were added.   Of the total culture 
medium volume, a maximum of 50% of ATE and 10% of PRP were applied on the cells 
in their respective culture media. The PRP concentration was optimized prior to the 
assay (data not shown). Subsequently, photography and digital measurements were done 
at distinct time points depending on the cell line (adipose stem cells 0h, 4h, 8h, 11h, 
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24h, 30h, 48h, 54h and 72h; keratinocytes 0h, 24h, 48h, 72h, 96h and 120h; endothelial 
cells 0h, 4h, 8h, 12h, 24h, 30h, 48h, 54h and 72h; fibroblasts 0h, 5h, 8h, 17h, 24h, 30h 
and 44h), using a digital camera (Nikon TS-100, Tokyo, Japan) connected to an inverted 
microscope (Nikon). Measurements were made until complete wound gap closure was 
reached in all the study wells. The results derived from independent experiments ATE 
(n=8), PRP (n=7) independent experiments were performed in duplicate or triplicate.  
2.9 Statistical analysis 
Statistical analysis and graph illustrations were performed with GraphPad Prism 5.0 
(GraphPad Software, Inc., San Diego, CA, USA). The data in this study is presented in 
mean and standard deviations. Differences were considered significant when p <0.05. 
Two-way ANOVA was employed to analyze cell proliferation and migration and two-
tailed paired t-test for analyzing the growth factors. 
 
3. Results  
3.1 Adipose Tissue Extract contains higher concentrations of KGF 
Mean protein concentrations were 0.4953 mg/ml (±0.155) for ATE donor samples with 
a range from 0.2450 to 0.8500 mg/ml. PRP had significantly overall higher (19 fold) 
growth factor concentrations.  KGF was the only growth factor that was significantly 
higher in ATE (p<0.05). Growth factors that were found to be significantly lower in 
ATE were: bFGF (p<0,05), VEGF (p<0.01), EGF (p<0.0505), IGF-1 (p<0.01), IL-6 
(p<0.01), for PDGF-B (p<0.001), TGF-β (p<0.01) and TNF-a (p<0.01). Figure 1 





 3.2 ATE promotes keratinocyte proliferation 
Cell proliferation assays were employed for keratinocytes, fibroblasts, adipose stem cells 
and endothelial cells to detect the growth of the studied cell populations in the presence 
of ATE or PRP at 1, 3 and 6 days of culture. Compared to the control cell culture media, 
results showed that ATE and PRP did not promote the proliferation of adipose stem 
cells, fibroblasts and endothelial cells during culture. Instead, both ATE and PRP 
seemed to proliferate slower during culture, especially PRP. However, ATE significantly 
induced (p<0.001) the proliferation of keratinocytes. The addition of 10% activated PRP 
supernatant did not promote keratinocyte proliferation either. Figure 2 illustrates cell 
proliferation of the four different cell lines during exposure to ATE and PRP.  
 
3.3 ATE stimulates fibroblast and adipose stem cell migration 
The addition of ATE to fibroblast cultures significantly induced their migration rate 
throughout the experiment, when compared both to the control group and to PRP group 
(both, p<0.001). Moreover, ATE significantly induced adipose stem cell migration 
during the culture (11 and 24 hours) when compared to the PRP group and to the control 
group (both p<0.001 and p<0.001 respectively). PRP seemed to share migration 
properties of the control group with fibroblast and adipose stem cells. For endothelial 
cells both treatment groups presented similar growth rates to controls, ATE group with 
significant difference to control at 24h (p<0.05). However, for keratinocytes, ATE and 
PRP both lead to significantly faster wound closure with significant difference to control 
at 75 hours time point (p<0.01 and p<0.001 respectively). Figure 3 illustrates the 
percentage of wound closure of the four studied cell lines at distinct time points in terms 
of percentage of original wound width in vitro. Figure 4 illustrates the phase contrast 
microscopic digital images of scratch wound assay of the four cells types at 24 hours. 
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4. Discussion 
Growth factors are paramount in cell signaling to promote complex, yet orchestrated 
events such as cell activation, proliferation, differentiation and migration leading to 
ultimate wound healing. Wound treatment with exogenous sources of growth factors 
has thus become increasingly popular (Salamanna et al. 2015), (Zhao et al. 2013). PRP 
has long been known as a source of these growth factors, however, individual 
variations in platelet count as well as differences in methods to prepare, activate and 
deliver PRP, make growth factor yields as well as clinical results variable (Leitner et 
al., 2006) (Rutkowski et al., 2008), (Weibrich et al., 2004), (Salamanna et al., 2015). 
Adipose tissue and its stromal vascular fraction arise as an alternative source of 
growth factors (Tamama and Kerpedjieva 2012), (Sarkanen et al., 2012a and 2012b). 
Many authors have previously suggested that adipose derived stem cell conditioned 
media and advanced adipose derived stem cell protein extract contains growth factors 
that accelerate and improve in vitro wound closure and cell proliferation (Kilroy et al. 
2007)- (Walter et al. 2010).  In this study, the authors tested the in vitro wound healing 
potential of adipose tissue preparation compared to platelet rich plasma in cell 
migration and proliferation assays. The adipose preparation contains soluble 
extracellular matrix components like growth factors, cytokines and extracellular 
matrix components (Sarkanen et al 2012), (Lopez et al., 2016).  Our aim was to study 
how cells respond to these growth factor sources and their mechanism.  
 When studying the concentrations of the principal growth factors affecting 
wound healing in PRP and ATE, we found that all growth factors, with the exception of 
KGF (FGF-7) were significantly higher in PRP specimens.  KGF, present significantly 
higher in ATE than in PRP, is a potent epithelial cell-specific growth factor secreted 
by stromal fibroblasts and acts as one of the main inducers of keratinocyte 
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proliferation, maturation and migration in wound healing (Seeger and Paller 2015), 
(Frank et al., 2000) and its activity is exhibited in keratinocytes but not in fibroblasts 
and endothelial cells. Additionally KGF plays a role in stimulating the production of 
other growth factors that promote wound healing (Lucarelli et al., 2003).   The finding 
that ATE contains enhanced quantities of KGF compared to PRP can be explained by 
the nature of mature adipose tissue, that is a combination of several cells, among these 
fibroblasts, included in a rich network of stromal cells, responsible for secreting KGF. 
The growth factor concentrations found in ATE correspond to our previous studies 
(Sarkanen et al 2012), (Lopez et al., 2016). Similarly, PRP growth factor 
concentrations, although variable, correlate with published experiments (Leitner et al., 
2006), (Rutkowski et al., 2008), (Weibrich et al., 2002). 
 Walter et al showed that mesenchymal stem cell conditioned medium 
accelerated fibroblast and keratinocyte migration in vitro, and fibroblasts migrated 
faster than keratinocytes (Walter et al., 2010). This result is in line with our study, 
where fibroblast and adipose stem cell migration were significantly accelerated, 
followed by a slower, although induced migration of keratinocytes, when compared to 
control. In contrast to Walter’s experiments that tested the proliferation in the 
presence of bone derived mesenchymal stem cell conditioned medium, we also 
observed a significant acceleration of cell proliferation with keratinocytes with the 
addition of ATE. ATE also seemed to stimulate cell proliferation of adipose stem 
cells, fibroblasts, keratinocytes and endothelial cells compared to PRP-treated cells. 
The significantly accelerated keratinocyte proliferation is in line with our 
results of high concentration of KGF in ATE. Once activated by KGF, keratinocytes 
proliferate and form a structured epithelial protective barrier that withstands potential 
chemical, mechanical and microbial noxa (Nolte et al., 2008), (Wright et al., 2009), 
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(Lee et al., 2016), (Sarkanen et al., 2011). Moreover, we found that in addition to 
KGF, ATE yielded appreciable quantities of PDGF-B, TGF-β, EGF, IGF-1 and bFGF 
that stimulate fibroblast migration and keratinocyte proliferation, detected in our studies. 
In addition, several other growth factors present in ATE, e.g. leptin (Sarkanen et al., 
2012), have been shown to promote keratinocyte proliferation and wound re-
epithelialization (Frank et al., 2000). Fibroblasts are crucial cells during the 
proliferative and remodeling phases of wound healing (Nolte et al., 2008), (Wright et 
al., 2009). The influx of fibroblasts forms a matrix scaffold that is not only the 
foundation for the primitive wound scar, but also a stable highway over which 
keratinocytes migrate and endothelial cells proliferate to form healthy, vascularized 
regenerated tissue (Lee et al., 2016). Accelerated keratinocyte proliferation then 
translates clinically as a quicker formation of a stable and stronger wound bed with the 
ability to scar in an orderly fashion, in quicker wound closure, which results in greater 
patient comfort, less pain and decreased dressing-related costs.  
 Wound treatment with autologous and recombinant PRP has 
demonstrated satisfactory wound healing outcomes in vivo (Demidova-Rice et al., 
2012). However, contradictory in vitro results have also been found. The growth-
stimulating effect of PRP has been reported to show dose-dependent behavior 
(Lucarelli et al. 2003), (Gruber et al. 2004), (Kilian et al. 2004), (Soffer et al. 2004). 
Barsotti et al. studied the effect of platelet lysate at 10% and 20% in four different cell 
lines and noticed that low concentrations induced greater cell viability, proliferation 
and migration while the highest concentration seemed to provoke angiogenesis 
(Barsotti et al., 2013). We also optimized the PRP concentration in our preliminary 
studies (data not shown) and found that lower concentrations of PRP (10% vs 20%) 
resulted in greater cell proliferation. However, in contrast to e.g. Barsotti et al., our 
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experiments demonstrated slow and stagnant in vitro cell proliferation for PRP treated 
cultures. We did not find any proliferative effect with PRP in vitro, only slight 
acceleration in keratinocyte migration. Our findings are supported by published 
experiments that have failed to find a direct relationship of PRP with cell proliferation 
(Graziani ; Liu et al. 2002; Xian et al. 2015). A possible reason for this negative effect 
of PRP on cell growth may be related to the excessively high concentrations of growth 
factors, among these, interferon gamma (IFN-γ) that inhibits fibroblast proliferation 
(Nolte et al., 2008), (Wright et al., 2009), (Lee et al., 2016), which was seen in our study. 
Additionally, PRP contains regulators found in platelet α-granules named 
thrombospondins (TBSP) (Hsu et al., 2009). In our previous studies, ATE has been 
found to contain only low amounts or not at all of IFN-γ and TBSP (Sarkanen et al., 
2012). In vitro, this family of proteins, in particular TBSP 1 and 2, have demonstrated 
anti-angiogenic effects, as well as negative effects on cell adhesion, proliferation and 
migration (Armstrong and Siadak 2002), (Iruela-Arispe et al., 1999). Even though cell 
differentiation and proliferation are essential for wound healing, both do not occur 
simultaneously. PRP, with its high concentration of platelet-derived growth factors, 
may support cell differentiation more than proliferation (Graziani), (Weibrich et al. 
2004).  The concentration of leukocytes in PRP has proven to induce pro-
inflammatory states, resulting in deleterious effects on cell proliferation in vitro 
(Anitua E at al., 2015). According to the growth factors that ATE and PRP contain, e.g. 
TGF-β, bFGF and PDGF-B reported here and previously (Sarkanen et al., 2012), they 
also contribute to the formation of extracellular matrix. This may also explain the 
differential results obtained for PRP in vitro and in vivo. 
 It therefore seems, also according to our study, that very high concentrations 
of growth factors are not a prerequisite for optimal cell proliferation and migration in 
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vitro. High concentrations of growth factors, as observed in PRP, insinuated to be 
more a hindrance than an advantage. Healing is, in fact, known to be disturbed by 
both under and over production of growth factors (Nolte et al., 2008), (Wright et al., 
2009), (Lee et al., 2016). When growth factor concentrations are below normal there 
is a delay in healing (Nolte et al., 2008), (Wright et al., 2009). On the other hand, an 
excess of certain regulatory growth factors can prevent the necessary steps for wound 
healing (Salamanna et al., 2015). Understanding the relationship between growth 
factors and their cellular environment could aid in predicting the clinical outcomes in 
the treatment with ATE or PRP.  
Adipose derived stem cells reflect mesenchymal cells that have the ability to 
differentiate towards a variety of cell lines. They have shown in vitro and in vivo 
advantages in cell regeneration and wound repair (Tamama and Kerpedjieva 2012), 
(Cohen 2008), (Balfour and Noble 1999). The addition of ATE to these cells resulted in 
stimulated proliferation and migration, which could also be in itself a therapeutic 
alternative. Our previous results, where also adipose stem cell differentiation was 
induced, support this (Sarkanen et al., 2012). Although our results are very promising 
for the use of ATE clinically in wound healing, in vitro assays do not reflect the 
complete complex microenvironment found in in vivo wound repair, and therefore can 
be used only for predicting and estimating the possible clinical outcomes. Another 
shortcoming with the use of ATE is that the current extraction procedure requires 
liposuction from the patient in order to obtain ATE. Therefore, the extraction 
procedure is unsuitable for very lean patients. Furthermore, ATE requires correct 
handling and preservation for optimal biological effect. Currently, further in vivo 
studies are being performed to support our findings and to further develop the 
procedures.  
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5. Conclusions  
ATE is an easy to obtain, alternative source of growth factors derived from adipose 
tissue with the ability to promote wound healing in vitro. Compared to PRP, ATE 
seems to provide more optimal amount of growth factors involved in wound healing. 
Especially the high concentration of KGF, responsible for keratinocyte growth and 
maturation as well as inducing the secretion of other growth factors, could be a key 
feature in ATE. As epithelization is an important step in optimal wound healing with 
minimal scar formation, ATE could be considered for treatment of wounds in the 
clinical setting. This unique advantage of ATE, containing the adequate 
measurements of growth factors at ideal concentrations, may hold the key to future 
therapeutics in tissue healing and regeneration 
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Fig. 1 Medians of the growth factors measured with ELISA for ATE and PRP patient 
samples. For PRP n=9 except for KGF n=10, and for PDGF-B n=8.  For ATE n=13 
except for PDGF-B n=11. The statistical analysis was performed with two-tailed 






Fig. 2 Cell proliferation of ATE and PRP-treated cultures of adipose stem cells, 
endothelial cells, fibroblasts and keratinocytes when compared to control. 
Proliferation was measured with Presto Blue from live cultures at days 0, 1, 3 and 6. 
Results are depicted as mean± SD. The statistical analysis was performed with two-
way ANOVA with Tukey’s post-test. Differences were considered significant when 
p<0.05*, p<0.01** and p<0.001***. Significances between ATE and control group 
are shown with (*), significances between PRP and control group with (#) and 





Fig. 3 In vitro scratch wound assays represented in percentages of original wound width. 
Cell migration of the four studied cell types was measured under microscopic at 
determined time points until complete wound closure was achieved. In all treatment 
groups, adipose stem cells reached wound closure within 74h, endothelial cells within 
25h, fibroblasts within 30h and keratinocytes within 125h. Results are depicted as 
mean± SD. The statistical analysis was performed with two-way ANOVA with 
Tukey’s post-test. Differences were considered significant when p<0.05*, p<0.01** 
and p<0.001***. Significances between ATE and control group are shown with (*), 
significances between PRP and control group with (#) and significances between ATE 





Fig. 4 Phase contrast microscopic images of in vitro cell migration after scratch 
wound assays of fibroblasts, endothelial cells, keratinocytes and adipose stem cells at 
24h timepoint. Cells were plated with the following counts: keratinocytes 300000 
cells/cm2, fibroblasts 100000 cells/cm2, adipose stem cells 100000 cells/cm2 and 
endothelial cells 150000 cells/cm2. These cultures were treated with ATE, PRP or with 
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